Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,
Journal Year:
2024,
Volume and Issue:
1879(4), P. 189124 - 189124
Published: May 25, 2024
Apoptosis
has
traditionally
been
regarded
as
the
desired
cell
death
pathway
activated
by
chemotherapeutic
drugs
due
to
its
controlled
and
non-inflammatory
nature.
However,
recent
discoveries
of
alternative
pathways
have
paved
way
for
immune-stimulatory
treatment
approaches
in
cancer.
Ferroptosis
(dependent
on
iron)
cuproptosis
copper)
hold
promise
selective
cancer
targeting
overcoming
drug
resistance.
Copper
ionophores
iron-bearing
nano-drugs
show
potential
clinical
therapy
single
agents
adjuvant
treatments.
Here
we
review
up-to-date
evidence
involvement
metal
ion-dependent
cytotoxicity
classical
(alkylating
agents,
topoisomerase
inhibitors,
antimetabolites,
mitotic
spindle
inhibitors)
their
combinations
with
ferroptosis
inducers,
indicating
prospects,
advantages,
obstacles
use.
Cell Death Discovery,
Journal Year:
2022,
Volume and Issue:
8(1)
Published: Dec. 29, 2022
Ferroptosis
is
a
new
iron-dependent
form
of
programmed
cell
death
characterized
by
iron
accumulation
and
lipid
peroxidation.
In
recent
years,
ferroptosis
has
garnered
enormous
interest
in
disease
treatment
research
communities
pursuit
to
reveal
the
mechanism
key
targets
because
closely
related
pathophysiological
processes
many
diseases.
Recent
studies
have
shown
some
targets,
such
as
glutathione
peroxidase
4
(GPX4)
System
Xc-,
several
inducers
inhibitors
been
developed
regulate
these
targets.
With
emergence
on
made
developments.
The
selection
use
are
very
important
for
work.
This
paper
briefly
introduces
regulatory
metabolic
pathway,
lists
categorizes
commonly
used
recently
inhibitors,
discusses
their
medical
application.
ends
with
potential
future
direction
ferroptosis.
Cell Death and Disease,
Journal Year:
2022,
Volume and Issue:
13(2)
Published: Feb. 24, 2022
Acute
kidney
injury
(AKI)
is
a
major
public
health
problem
with
high
incidence
and
mortality.
As
form
of
programmed
cell
death
(PCD),
ferroptosis
could
be
considered
as
process
iron
accumulation
enhanced
lipid
peroxidation.
Recently,
the
fundamental
roles
in
AKI
have
attracted
much
attention.
The
network
mechanism
its
to
chronic
disease
(CKD)
transition
complicated
multifactorial.
Strategies
targeting
show
great
potential.
Here,
we
review
research
progress
on
participation
AKI.
We
hope
that
this
work
will
provide
clues
for
further
studies
Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: March 16, 2023
Deoxynivalenol
(DON)
is
a
widespread
issue
for
feed
and
food
safety,
leading
to
animal
human
health
risks.
The
objective
of
this
study
was
determine
whether
ferroptosis
involved
in
DON-induced
intestinal
injury
piglets.
Three
groups
21-day-old
male
weanling
piglets
(n
=
7/group)
were
fed
control
diet,
or
diet
adding
1.0
3.0
mg
DON/kg.
At
week
4,
serum
small
intestines
collected
assay
biochemistry,
histology,
redox
status
ferroptosis-related
genes
expression.
In
addition,
the
involvement
role
FTL
gene
cell
death
further
verified
IPEC-J2
cells.Compared
control,
dietary
supplementation
DON
at
mg/kg
induced
different
degrees
damage
duodenum,
jejunum
ileum,
increased
(P
<
0.05)
lipopolysaccharide
concentration
by
46.2%-51.4%.
Dietary
(or)
concentrations
malondialdehyde
(17.4%-86.5%)
protein
carbonyl
33.1%-92.3%
ileum.
supplemented
with
upregulated
ferroptotic
(DMT1)
anti-ferroptotic
(FTL
FTH1),
while
downregulated
(FPN,
FSP1
CISD1)
duodenum
porcine.
Furthermore,
vitro
has
demonstrated
that
deferiprone,
potent
inhibitor,
mitigated
cytotoxicity
porcine
cells.
Additionally,
deferiprone
prevented
alleviated
dysregulation
(ACSL4
FTL)
Moreover,
specific
siRNA
knockdown
expression
compromised
cells.In
conclusion,
revealed
porcine,
sheds
new
light
on
toxicity
Cancers,
Journal Year:
2024,
Volume and Issue:
16(3), P. 647 - 647
Published: Feb. 2, 2024
Copper,
an
essential
element
for
various
biological
processes,
demands
precise
regulation
to
avert
detrimental
health
effects
and
potential
cell
toxicity.
This
paper
explores
the
mechanisms
of
copper-induced
death,
known
as
cuproptosis,
its
disease
implications,
including
cancer
therapy.
Copper
ionophores,
such
elesclomol
disulfiram,
increase
intracellular
copper
levels.
elevation
triggers
oxidative
stress
subsequent
offering
implications
in
Additionally,
ionophores
disrupt
mitochondrial
respiration
protein
lipoylation,
further
contributing
toxicity
death.
Potential
targets
biomarkers
are
identified,
can
be
targeted
those
proteins
trigger
cuproptosis.
The
role
different
cancers
is
discussed
understand
therapies
using
nanomaterials,
chelators.
Furthermore,
explored
through
diseases
Wilson
Menkes
physiological
copper.
Exploring
cuproptosis
presents
opportunity
improve
treatments
copper-related
disorders
cancers,
with
bring
significant
advancements
modern
medicine.
Small,
Journal Year:
2024,
Volume and Issue:
20(25)
Published: Jan. 14, 2024
Abstract
Ferroptosis
is
a
new
form
of
regulated
cell
death
featuring
iron‐dependent
lipid
peroxides
accumulation
to
kill
tumor
cells.
A
growing
body
evidence
has
shown
the
potential
ferroptosis‐based
cancer
therapy
in
eradicating
refractory
malignancies
that
are
resistant
apoptosis‐based
conventional
therapies.
In
recent
years,
studies
have
reported
number
ferroptosis
inducers
can
increase
vulnerability
cells
by
regulating
ferroptosis‐related
signaling
pathways.
Encouraged
rapid
development
ferroptosis‐driven
therapies,
interdisciplinary
fields
combine
ferroptosis,
pharmaceutical
chemistry,
and
nanotechnology
focused.
First,
prerequisites
metabolic
pathways
for
briefly
introduced.
Then,
detail
emerging
designed
boost
ferroptosis‐induced
therapy,
including
metal
complexes,
metal‐based
nanoparticles,
metal‐free
nanoparticles
summarized.
Subsequently,
application
synergistic
strategies
with
apoptosis
other
emphasis
on
use
both
cuproptosis
induce
redox
dysregulation
intracellular
bimetallic
copper/iron
metabolism
disorders
during
treatment
discussed.
Finally,
challenges
associated
clinical
translation
future
directions
potentiating
therapies
highlighted.
Antioxidants and Redox Signaling,
Journal Year:
2021,
Volume and Issue:
37(1-3), P. 150 - 170
Published: Sept. 26, 2021
Significance:
Iron
accumulation
occurs
in
the
central
nervous
system
(CNS)
a
variety
of
neurological
conditions
as
diverse
spinal
cord
injury,
stroke,
multiple
sclerosis,
Parkinson's
disease,
and
others.
is
redox-active
metal
that
gives
rise
to
damaging
free
radicals
if
its
intracellular
levels
are
not
controlled
or
it
properly
sequestered
within
cells.
The
iron
due
dysregulation
mechanisms
control
cellular
homeostasis.
Recent
Advances:
molecular
regulate
homeostasis
have
been
revealed
much
detail
past
three
decades,
new
advances
continue
be
made.
Understanding
which
aspects
dysregulated
different
will
provide
insights
into
causes
iron-mediated
tissue
damage.
iron-dependent
lipid
peroxidation
leading
cell
death,
called
ferroptosis,
has
provided
useful
highly
relevant
for
lipid-rich
environment
CNS.
Critical
Issues:
This
review
examines
normal
homeostasis,
these
disorders,
more
recent
work
on
how
can
induce
damage
via
ferroptosis.
Future
Directions:
Quick
reliable
tests
needed
determine
when
ferroptosis
contributes
pathogenesis
disorders.
In
addition,
there
need
develop
better
druggable
agents
scavenge
reduce
CNS
currently
few
effective
treatments.
Antioxid.
Redox
Signal.
37,
150-170.
Redox Biology,
Journal Year:
2022,
Volume and Issue:
56, P. 102435 - 102435
Published: Aug. 23, 2022
Chronic
liver
injury
causing
fibrosis
is
a
major
cause
of
morbidity
and
mortality
worldwide.
Targeting
the
suppression
hepatic
stellate
cell
(HSC)
activation
recognized
as
an
effective
strategy
for
treatment
fibrosis.
Ellagic
acid
(EA),
natural
polyphenol
product
isolated
from
fruits
vegetables,
possesses
many
biological
functions.
Here,
EA
exerts
its
antifibrotic
activity
by
inducing
ferroptotic
death
activated
HSCs,
which
accompanied
redox-active
iron
accumulation,
lipid
peroxidation,
GSH
depletion
in
CCl4
mice
human
LX-2
cells.
The
specific
ferroptosis
inhibitor
ferrostatin-1
prevented
EA-induced
death.
Mechanistically,
impairs
formation
vesicle-associated
membrane
protein
2
(VAMP2)/syntaxin
4
VAMP2/synaptosome-associated
23
complexes
suppressing
VAMP2
expression
enhancing
degradation
proteasome-dependent
pathway.
This
leads
to
impairment
ferroportin
(FPN,
exporter)
translocation
intracellular
extrusion.
Interestingly,
overexpression
inhibits
role
blocking
FPN
increasing
ferritin
content
(an
storage
marker).
In
contrast,
knockdown
shows
synergistic
effect
on
EA-mediated
events
both
HSCs.
Additionally,
HSC-specific
impaired
HSC
mouse
fibrosis,
increased
inhibitory
Taken
together,
our
data
suggest
that
effects
FPN-dependent
HSCs
disrupting
SNARE
complexes,
will
hopefully
serve
prospective
compound
treatment.
Molecular Medicine Reports,
Journal Year:
2022,
Volume and Issue:
25(4)
Published: Feb. 15, 2022
Polycystic
ovary
syndrome
is
one
of
the
most
common
endocrine
and
metabolic
gynecological
disorders,
which
dysfunction
ovarian
granulosa
cells
a
key
contributing
factor.
The
aim
present
study
was
to
explore
role
ferrostatin‑1
(Fer‑1),
ferroptosis
inhibitor,
in
cell
injury
model
established
by
homocysteine
(Hcy)‑induced
KGN
line
potential
underlying
mechanism.
Cell
viability
measured
using
Counting
Kit‑8
assay
presence
or
absence
Hcy
Fer‑1.
apoptosis
assessed
TUNEL
staining
expression
levels
apoptosis‑related
proteins
were
western
blotting.
To
effects
Fer‑1
on
oxidative
stress
Hcy‑treated
cells,
reactive
oxygen
species
(ROS),
malondialdehyde
(MDA),
lactate
dehydrogenase
(LDH)
glutathione
(GSH)
their
corresponding
kits.
Furthermore,
Fe2+
Phen
Green™
SK
labeling
blotting
performed
measure
protein
ferroptosis‑associated
GPX4,
SLC7A11,
ASCL4
DMT1.
Subsequently,
DNA
methylation
ten‑eleven
translocation
(TET)
1/2
demethylase
also
detected
evaluate
extent
overall
after
treatment.
TET1/2
inhibitor
Bobcat339
hydrochloride
applied
treat
before
evaluating
possible
methylation.
found
markedly
elevate
following
rate
Fer‑1‑treated
groups
decreased,
accompanied
downregulated
Bax
cleaved
caspase‑3
upregulated
Bcl‑2
expression.
In
addition,
treatment
reduced
ROS,
MDA
LDH
whilst
enhancing
GSH.
significantly
decreased
treatment,
elevated
peroxidase
4
reducing
solute
carrier
family
7
member
11,
achaete‑scute
BHLH
transcription
factor
divalent
metal
transporter
1
inhibited
enhanced
levels,
reversed
with
hydrochloride.
Subsequent
experiments
viability,
stress,
content,
ferroptosis‑
revealed
that
Hcy‑induced
injury.
These
results
suggest
may
potentially
protect
against
increasing
TET